Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is IDEXX Laboratories Stock Outperforming the S&P 500?

IDEXX Laboratories, Inc. (IDXX) is a Westbrook, Maine-based leader in veterinary diagnostics, software, and water testing solutions. Valued at a market cap of $45.7 billion, the company develops and supplies diagnostic instruments, test kits, software, and laboratory services that help veterinarians, farmers, and laboratories detect diseases and monitor animal health.

Companies worth $10 billion or more are typically classified as “large-cap stocks,” and IDXX fits the label perfectly. IDEXX is widely regarded as a market leader in veterinary diagnostics, benefiting from strong brand recognition, a large installed base of diagnostic instruments in veterinary clinics, and a recurring revenue model driven by...

Fundamentals

See More
  • Market Capitalization, $K 48,806,440
  • Shares Outstanding, K 422,128
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,488 M
  • EBITDA $ 3,975 M
  • 60-Month Beta 0.95
  • Price/Sales 5.16
  • Price/Cash Flow 15.28
  • Price/Book 15.30

Options Overview Details

View History
  • Implied Volatility 31.65% (-1.39%)
  • Historical Volatility 26.84%
  • IV Percentile 62%
  • IV Rank 38.00%
  • IV High 46.55% on 04/07/25
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 4) 2.73 (2.31%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 1,058
  • Volume Avg (30-Day) 1,647
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 65,970
  • Open Int (30-Day) 64,640
  • Expected Range 115.42 to 120.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.61
  • Number of Estimates 11
  • High Estimate 1.69
  • Low Estimate 1.55
  • Prior Year 1.48
  • Growth Rate Est. (year over year) +8.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.47 +3.21%
on 03/13/26
132.30 -10.70%
on 02/27/26
-8.50 (-6.71%)
since 02/13/26
3-Month
114.47 +3.21%
on 03/13/26
132.49 -10.82%
on 02/12/26
-5.08 (-4.12%)
since 12/16/25
52-Week
114.47 +3.21%
on 03/13/26
172.23 -31.40%
on 06/03/25
-43.11 (-26.73%)
since 03/14/25

Most Recent Stories

More News
Is IDEXX Laboratories Stock Outperforming the S&P 500?

Despite outperforming the broader S&P 500 Index over the past year, analysts maintain a cautiously optimistic outlook on IDEXX Laboratories’ future prospects.

$SPX : 6,699.38 (+1.01%)
ZTS : 118.15 (+2.19%)
IDXX : 586.37 (+2.19%)
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

ZTS : 118.15 (+2.19%)
HAE : 59.70 (-0.37%)
ELV : 292.07 (+0.15%)
Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026...

ZTS : 118.15 (+2.19%)
Zoetis to Participate in Upcoming Investor Conferences

Zoetis Inc. (NYSE:ZTS) today announced that Wetteny Joseph, Executive Vice President and Chief Financial Officer, will participate in fireside chats at the following investor conferences. ...

ZTS : 118.15 (+2.19%)
Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation

Acquisition strengthens Zoetis’ leadership in Precision Animal Health by integrating Neogen’s global genomics capabilities, expanding predictive insights and individualized care worldwide

ZTS : 118.15 (+2.19%)
NEOG : 9.11 (+0.22%)
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.

XLV : 151.01 (+0.81%)
ZTS : 118.15 (+2.19%)
UTHR : 534.30 (-0.34%)
2 Reasons to Like ZTS (and 1 Not So Much)

2 Reasons to Like ZTS (and 1 Not So Much)

ZTS : 118.15 (+2.19%)
Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2026 Animal Health Summit on Thursday, February 26, 2026 at 1:15 p.m. ET. Wetteny Joseph, Executive Vice President and...

ZTS : 118.15 (+2.19%)
The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

ZTS : 118.15 (+2.19%)
2 S&P 500 Stocks to Research Further and 1 We Question

2 S&P 500 Stocks to Research Further and 1 We Question

WM : 236.96 (-0.66%)
GM : 72.95 (+0.77%)
ZTS : 118.15 (+2.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 122.60
2nd Resistance Point 120.57
1st Resistance Point 119.36
Last Price 118.15
1st Support Level 116.12
2nd Support Level 114.09
3rd Support Level 112.88

See More

52-Week High 172.23
Fibonacci 61.8% 150.17
Fibonacci 50% 143.35
Fibonacci 38.2% 136.53
Last Price 118.15
52-Week Low 114.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar